Simpo, Florencia M.

HRN: 22-59-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
CEFTRIAXONE 1G (VIAL)
02/14/2023
02/20/2023
IV
2g
Q24
UTI
Waiting Final Action 
02/18/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/18/2023
02/25/2023
IV
2.25g
Q6hrs As Iv Infusion
T/C Aspiration Pneumonka
Waiting Final Action 
02/18/2023
METRONIDAZOLE 500MG (TAB)
02/18/2023
02/28/2023
IV
500 Mg
Q6
Aspiration Pneumonia
Waiting Final Action 
02/22/2023
MUPIROCIN 2%, 15G (TUBE)
02/22/2023
03/01/2023
TOPICAL
2%
BID
Ruptured Blisters
Waiting Final Action 
02/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/25/2023
02/28/2023
IV
500mg
TID
Aspiration Pneumonia
Waiting Final Action 
03/01/2023
CEFUROXIME 1.5GM (VIAL)
03/01/2023
03/07/2023
IV
1.5g
Q8
Aspiration Pneumonia, CAP HR
03/06/2023
MUPIROCIN 2%, 15G (TUBE)
03/06/2023
03/12/2023
TOPICAL
2%
BID
Bedsore
Waiting Final Action 
03/08/2023
CEFTAZIDIME 1GM (VIAL)
03/08/2023
03/21/2023
IV
1g
Q12
CVD Bleed, Intubated
Waiting Final Action 
03/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/14/2023
03/20/2023
IV
500 Mg
Q6H
Infectious Diarrhea
Waiting Final Action 
03/18/2023
MUPIROCIN 2%, 15G (TUBE)
03/18/2023
03/25/2023
TOPICAL
2%
BID
Ruptured Blisters
Waiting Final Action 
03/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/20/2023
03/26/2023
IVT
250mg
Q8
Sepsis
Waiting Final Action 
03/20/2023
MUPIROCIN 2%, 15G (TUBE)
03/20/2023
03/26/2023
TOPICAL
1 Squirt
BID
Soft Tissue Infection
Waiting Final Action 
03/20/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/20/2023
03/26/2023
TOPICAL
1 Squirt
BID
Ulceration
Waiting Final Action 
03/27/2023
MUPIROCIN 2%, 15G (TUBE)
03/27/2023
04/03/2023
TOPICAL
5%
BID
Soft Tissue Infection
Waiting Final Action 
03/27/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/27/2023
04/03/2023
TOPICAL
1%
BID
Soft Tissue Infection
Waiting Final Action 
03/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/29/2023
04/04/2023
IV
4.5g
Q6
Sepsis; Cap HR
Waiting Final Action 
03/31/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/31/2023
04/06/2023
IV
750 Mg
OD
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: